Pemetrexed and Cisplatin Show Promise As Mesothelioma Treatment
Wednesday, October 15th, 2008Investigators announced the findings from phase 3 studies, which found that cisplatin plus an antifolate — either pemetrexed or raltitrexed — increase survival in patients with mesothelioma nearly 3-fold.
The latest findings from a number of trials were announced at the European Respiratory Society 2008 Annual Congress by Thierry Berghmans, MD, from the department of […]
Lung Cancer Trial Uses Chemo-Radiation Therapy for Pleural Mesothelioma
Monday, August 4th, 2008Posted on AsbestosHUB.
Patients are being recruited for a clinical trial of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung’s lining that’s almost always caused by exposure to asbestos.
Currently, the standard treatment is to remove the affected lung.
“Current surgical and chemotherapy treatments of patients with malignant […]
New Clinical Trial for Mesothelioma Patients
Monday, June 30th, 2008Posted on AsbestosHub.
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at New York Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma.
The standard treatment for pleural mesothelioma is currently surgery to […]
New Cancer Drug Arenegyr Gets Boost in Europe
Wednesday, June 25th, 2008MolMed S.p.A. announced in June 2008 that the European Commission has granted Orphan Drug designation for MolMed’s investigational new antitumour therapeutic drug ARENEGYR (NGR-hTNFa) in the treatment of malignant pleural mesothelioma. The Commission decision follows the positive opinion released on April 9 by the Committee for Orphan Medicinal Products of the […]
UK Man Dies After Lung Unnecessarily Removed
Monday, June 9th, 2008John Turner, 61, of Cumbria, UK, died after being wrongly diagnosed with asbestos cancer and removed a healthy lung in an attempt to prolong his life.
Mr. Turner was told it was possible to extend his life by three years if he agreed to have his ‘diseased’ right lung removed. He consented but never fully recovered […]
Onconase Shows Promise in Some Malignant Mesothelioma Patients
Thursday, June 5th, 2008Onconase (Ranpirnase) is a new drug in Phase IIIb clinical trials for the treatment of cancer. It is comprised of a natural protein isolated from the leopard frog, and has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. Onconase triggers apoptosis, the natural death of […]
Aspirin and Platinum to Treat Mesothelioma?
Monday, May 26th, 2008Nonsteroidal anti-inflammatory drugs (NSAIDs, a drug class which includes aspirin) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam (manufactured under the brand name Feldene) in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (a platinum-based chemotherapy drug) on mesothelioma cells.
The […]
